Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

20 Sep 2017 07:00

RNS Number : 1924R
Standard Life Private Eqty Trst PLC
20 September 2017
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2017

 

· The Company's net asset value ("NAV") per ordinary share increased by 5.9% to 390.6 pence for the quarter ended 30 June 2017

· Realised gains and income during the quarter ended 30 June 2017 were £16.0 million (2.8% of NAV). The unrealised gains on the portfolio on a constant exchange rate basis were £10.0 million (1.8% of NAV); in addition, there were unrealised foreign exchange gains of £8.3 million (1.5% of NAV)

· 93.2% by value of the portfolio was valued by the respective underlying managers at 30 June 2017

· NAV total return was 13.7% for the nine months from 1 October 2016 to 30 June 2017.

· Outstanding commitments were £331.2 million at 30 June 2017

· Liquid resources were £111.6 million at 30 June 2017

 

For the quarter ended 30 June 2017 the Company's NAV increased by 5.9% to 390.6 pence per share, from 368.9 pence per share at 31 March 2017. At 30 June 2017 the Company's net assets were £600.5 million (31 March 2017 - £567.2 million). NAV total return was 13.7% for the nine months from 1 October 2016 to 30 June 2017.

 

The closing value of the Company's portfolio, which, included 50 private equity fund interests, was £488.2 million at 30 June 2017 (31 March 2017 - £470.2 million and 49 private equity fund interests). The total unrealised gains on the portfolio for the quarter ended 30 June 2017 were £18.3 million, comprising £10.0 million of unrealised gains on a constant exchange rate basis and £8.3 million of unrealised foreign exchange gains. The MSCI Europe Index (in sterling) and the FTSE All Share Index (in sterling) rose by 3.7% and 1.4% respectively during the quarter. The unrealised foreign exchange gains were driven by the euro appreciating by 2.6% relative to sterling over the quarter, offset by the US dollar depreciating 3.9% relative to sterling.

 

During the quarter ended 30 June 2017 the Company received £32.1 million of distributions (six months ended 31 March 2017 - £73.5 million) and funded £13.2 million of drawdowns (six months ended 31 March 2017 - £46.1 million). The distributions received during the quarter generated £16.0 million of net realised gains and income, which was equivalent to a return of 2.1 times the acquisition cost of the realised investments. Total distributions and drawdowns for the nine months ended 30 June 2017 were £105.6 million and £59.3 million, respectively.

 

The Company made one new fund commitment of €35.0 million to CVC Capital Partners VII. The Company had total outstanding commitments to its 50 private equity fund interests of £331.2 million at 30 June 2017 (31 March 2017 - £312.2 million and 49 private equity fund interests). The Manager continues to believe that around £60 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2017 the Company had liquid resources of £111.6 million comprised of cash and cash equivalents (31 March 2017 - liquid resources of £97.7 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

2. Activity since 30 June 2017

 

On 21 July 2017 the Company paid an interim dividend for the year ended 30 September 2017 of 6.0 pence per ordinary share. The cost of the interim dividend was £9.2 million.

 

During the period from 1 July to 8 September 2017 the Company funded £24.0 million of drawdowns and received £21.1 million of distributions.

 

A new commitment of €30.0 million was made to Nordic Capital Fund IX on 29 August. At 8 September 2017 the Company had liquid resources of £101.9 million. The Company also had total outstanding commitments of £344.9 million.

 

The Company's estimated NAV at 31 August 2017 is also being announced today. It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2017 on or around 4 December 2017.

 

 

For further information please contact:-

 

Roger Pim at SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life Aberdeen plc.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXKLFFDKFXBBQ
Date   Source Headline
4th Apr 202212:06 pmRNSChange of Name
22nd Mar 20222:14 pmRNSResult of AGM
21st Mar 202211:26 amRNSDirector Declaration
14th Mar 20225:30 pmRNSFTSE Russell Indices
14th Mar 20227:00 amRNSEstimated NAV at 28 February 2022
9th Mar 20222:07 pmRNSFirst Interim Dividend
24th Feb 20227:00 amRNSEdison review on Standard Life Private Equity Trst
14th Feb 20227:00 amRNSEstimated NAV at 31 January 2022
4th Feb 20223:24 pmRNSAnnual Report
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
27th Jan 20227:05 amRNSEstimated NAV at 31 December 2021
27th Jan 20227:00 amRNSAnnual Financial Report
6th Jan 20229:04 amRNSQuarterly disclosure
15th Dec 20217:00 amRNSEstimated NAV as at 30 November 2021
14th Dec 20213:48 pmRNSFourth Interim Dividend
6th Dec 20217:00 amRNSEdison review on Standard Life Private Equity Trst
12th Nov 20217:00 amRNSEstimated NAV at 31 October 2021
2nd Nov 20214:25 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSEstimated NAV at 30 September 2021
4th Oct 20214:15 pmRNSQuarterly disclosure
29th Sep 20217:02 amRNSEstimated NAV at 31 August 2021
29th Sep 20217:00 amRNSQuarterly Investment Update at 30 June 2021
17th Sep 20211:10 pmRNSUpdate research from QuotedData
7th Sep 20217:00 amRNSThird Interim Dividend
1st Sep 20217:00 amRNSDirectorate Change
16th Aug 202110:19 amRNSDirector/PDMR Shareholding
13th Aug 20217:00 amRNSEstimated NAV at 31 July 2021
10th Aug 20214:41 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
5th Aug 20213:32 pmRNSDirector/PDMR Shareholding
19th Jul 202111:58 amRNSEdison issues review on Standard Life Private
14th Jul 20219:05 amRNSDirector Declaration
14th Jul 20217:00 amRNSEstimated NAV at 30 June 2021
9th Jul 20213:29 pmRNSDoc re. Half yearly report
2nd Jul 20214:35 pmRNSQuarterly disclosure
29th Jun 20217:05 amRNSEstimated NAV at 31 May 2021
29th Jun 20217:00 amRNSHalf-year Report
14th Jun 20212:48 pmRNSSecond Interim Dividend
17th May 20217:00 amRNSEstimated NAV at 30 April 2021
12th May 20214:06 pmRNSDirector/PDMR Shareholding
27th Apr 202112:21 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:05 amRNSEstimated NAV at 31 March 2021
22nd Apr 20217:00 amRNSQuarterly Investment Update at 31 December 2020
9th Apr 202111:58 amRNSHolding(s) in Company
6th Apr 20214:11 pmRNSQuarterly disclosure
23rd Mar 20211:50 pmRNSResult of AGM
12th Mar 20217:00 amRNSEstimated NAV as at 28 February 2021
8th Mar 20217:00 amRNSFirst Interim Dividend
25th Feb 20217:00 amRNSEdison review on Standard Life Private Eqty Trust
12th Feb 202110:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.